Chovatiya R, Ribero S, Wollenberg A, Park C, Silvestre J, Hong H
Am J Clin Dermatol. 2025; .
PMID: 40085349
DOI: 10.1007/s40257-025-00931-1.
Lueangarun S, Techalert N, Tempark T
J Clin Aesthet Dermatol. 2025; 18(2):38-43.
PMID: 40078865
PMC: 11896615.
Silverberg J, Anderson P, Cappelleri J, Piercy J, Levenberg M, Myers D
Arch Dermatol Res. 2025; 317(1):556.
PMID: 40072609
PMC: 11903610.
DOI: 10.1007/s00403-025-03910-y.
Andersen L, Williams M, Pease S, Dhatt H, Delong P
Ther Innov Regul Sci. 2025; .
PMID: 40056370
DOI: 10.1007/s43441-025-00767-1.
Sellami I, Abbes A, Haddar A, Feki A, Kotti N, Halweni H
J Infect Prev. 2025; :17571774251324382.
PMID: 40051734
PMC: 11881100.
DOI: 10.1177/17571774251324382.
Life-Changing Decisions in Patients Suffering from Psoriasis: A Cross-Sectional Study.
Bien B, Krajewski P, Szepietowski J
Dermatol Ther (Heidelb). 2025; .
PMID: 40050518
DOI: 10.1007/s13555-025-01370-w.
Development and Validation of a Disease-specific Outcomes Tool for the Assessment of Patient Benefits of Treatment for Hidradenitis Suppurativa: the PBI-HS.
Kirsten N, Augustin M, Blome C, Topp J, Schwager R, Bechara F
Acta Derm Venereol. 2025; 105:adv41298.
PMID: 40047385
PMC: 11898107.
DOI: 10.2340/actadv.v105.41298.
Baseline Pathological Liver Function Tests in Patients With Psoriasis Support the Indication for Systemic Therapy Rather Than Being a Reason Against It: A Real-World Analysis.
Krefting F, Scheib C, Benson S, Holsken S, Placke J, Wedemeyer H
Psoriasis (Auckl). 2025; 15:29-44.
PMID: 40046951
PMC: 11881625.
DOI: 10.2147/PTT.S502296.
Economic burden of atopic dermatitis in Portugal: a cross-sectional study.
Cunha A, Vitorino G, Silva J, Coelho P
Sci Rep. 2025; 15(1):7717.
PMID: 40044763
PMC: 11882976.
DOI: 10.1038/s41598-025-91896-y.
Commentary on "Capture of patient itch scores in practice reveals disparate itch impact based upon age, gender and race: A cross-sectional survey analysis.".
Chen S
JID Innov. 2025; 5(2):100352.
PMID: 40041426
PMC: 11876739.
DOI: 10.1016/j.xjidi.2025.100352.
Performance and Safety of the Medical Device Ialuxid Gel in the Treatment of Mild-Moderate Acne Vulgaris: An Open-Label, Noncomparative Multicentre Interventional Clinical Trial.
Stefancu M, Barattini D, Botnaru I, Vizman C, Stucchi L, Barattini L
J Cosmet Dermatol. 2025; 24(3):e70084.
PMID: 40029154
PMC: 11875049.
DOI: 10.1111/jocd.70084.
Effects and safety of acupuncture versus non-penetrating sham acupuncture for senile pruritus: Rationale and design for a randomized controlled trial.
Chen H, Liu S, Gao S, Yi J, Shi H, Fang J
Contemp Clin Trials Commun. 2025; 44:101454.
PMID: 40027278
PMC: 11872407.
DOI: 10.1016/j.conctc.2025.101454.
New tool in our arsenal: efficacy of injectable platelet-rich fibrin (i-PRF) in androgenetic alopecia treatment.
Yao S, Chen X, Li S, Zhou L, Bai Q, Zhao C
Arch Dermatol Res. 2025; 317(1):493.
PMID: 40009221
DOI: 10.1007/s00403-025-04038-9.
Association of Myo-Inositol and Microlipodispersed Magnesium in Androgen-Dependent Dermatological Diseases: A Retrospective Study.
Pezza M, Carlomagno V, Sammarco E, Trischitta A, Ceddia C, Vitiello A
Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40006064
PMC: 11859446.
DOI: 10.3390/ph18020251.
Prevalence and Burden of Chronic Spontaneous Urticaria in Japan: A Cross-Sectional Study.
Hide M, Uda A, Maki F, Miyakawa N, Kohli R, Gupta S
J Clin Med. 2025; 14(4).
PMID: 40004692
PMC: 11856825.
DOI: 10.3390/jcm14041162.
Association Between Systemic Inflammation, Metabolic Syndrome and Quality of Life in Psoriasis Patients.
Mustata M, Neagoe C, Radulescu V, Dragne I, Cimpeanu R, Radu L
Life (Basel). 2025; 15(2).
PMID: 40003621
PMC: 11856174.
DOI: 10.3390/life15020212.
Chronic kidney disease-associated pruritus and patient-centred outcomes: a systematic review.
Wang T, Goh J, Seth S, Do L, Tesfaye W, Sud K
J Nephrol. 2025; .
PMID: 40000587
DOI: 10.1007/s40620-025-02221-9.
Validation of the vitiligo-specific quality-of-life instrument (VitiQoL) for the Turkish language: the VitiQoL-TR study.
Kurt B, Sayili U, Ocal Durmus D, Kayaalti A, Cetinkaya P, Aksu A
Arch Dermatol Res. 2025; 317(1):478.
PMID: 39987536
DOI: 10.1007/s00403-025-03968-8.
Benefits and Satisfaction with Apremilast Treatment in Patients with Psoriasis Affecting the Genital Area: Secondary Analysis of the APPRECIATE Study.
da Silva Burger N, Tran K, Typou M, Sommer R, Neasham D, Cordey M
Dermatol Ther (Heidelb). 2025; 15(3):681-695.
PMID: 39969771
DOI: 10.1007/s13555-025-01360-y.
Restless Legs Syndrome in Psoriasis: A Multicenter Study on Its Prevalence, Severity, and Impact on Patients.
Nguyen C, Nguyen N, Van T
Clin Cosmet Investig Dermatol. 2025; 18:367-378.
PMID: 39968328
PMC: 11832437.
DOI: 10.2147/CCID.S502902.